Rasburicase has been defined as a potent urolyticagent for management of malignancy-associatedhyperuricemia. We reviewed the data of 26 childrenwith malignancy at risk for TLS who received rasburicasefor treatment or prophylaxis of acute hyperuricemia,producing a significant decrease in uric acidlevel in all the patients. Tolerance of treatment wasexcellent. Rasburicase is a safe, highly and rapidlyeffective agent in the treatment and prevention ofmalignancies-associated acute hyperuricemia.

EFFICACY AND SAFETY OF RECOMBINANT URATE OXIDASE (RASBURICASE) FOR TREATMENT AND PROPHYLAXIS OF HYPERURICEMIA IN CHILDREN UNDERGOIN CHEMIOTHERAPY / A., Pession; E., Barbieri; N., Santoro; Paolucci, Paolo; F., Porta; F., Locatelli. - In: JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. - ISSN 1077-4114. - STAMPA. - 90:(2005), pp. 141-142.

EFFICACY AND SAFETY OF RECOMBINANT URATE OXIDASE (RASBURICASE) FOR TREATMENT AND PROPHYLAXIS OF HYPERURICEMIA IN CHILDREN UNDERGOIN CHEMIOTHERAPY.

PAOLUCCI, Paolo;
2005

Abstract

Rasburicase has been defined as a potent urolyticagent for management of malignancy-associatedhyperuricemia. We reviewed the data of 26 childrenwith malignancy at risk for TLS who received rasburicasefor treatment or prophylaxis of acute hyperuricemia,producing a significant decrease in uric acidlevel in all the patients. Tolerance of treatment wasexcellent. Rasburicase is a safe, highly and rapidlyeffective agent in the treatment and prevention ofmalignancies-associated acute hyperuricemia.
90
141
142
EFFICACY AND SAFETY OF RECOMBINANT URATE OXIDASE (RASBURICASE) FOR TREATMENT AND PROPHYLAXIS OF HYPERURICEMIA IN CHILDREN UNDERGOIN CHEMIOTHERAPY / A., Pession; E., Barbieri; N., Santoro; Paolucci, Paolo; F., Porta; F., Locatelli. - In: JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. - ISSN 1077-4114. - STAMPA. - 90:(2005), pp. 141-142.
A., Pession; E., Barbieri; N., Santoro; Paolucci, Paolo; F., Porta; F., Locatelli
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/456430
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 4
social impact